Bio-Imaging Technologies Secures $1.1 Million Contract with Pharmacyclics

Bio-Imaging Technologies, Inc., a biomedical information technology and services company, has entered into a contract with Pharmacyclics, Inc. to provide medical image processing and digital image management services for a phase III clinical trial of Pharmacyclics' Gd-Tex radiation sensitizer. The contract is valued at approximately $1.1 million and marks the continuation of a four-year partnership between the two companies. This collaboration underscores the utility of Bio-Imaging's medical image processing technology and drug development expertise, highlighting the importance of building solid client relationships.

Key Takeaways:

• Bio-Imaging Technologies has signed a $1.1 million contract with Pharmacyclics, Inc. to provide medical image processing and digital image management services for a phase III clinical trial.
• The contract represents the continuation of a four-year partnership between Bio-Imaging Technologies and Pharmacyclics, Inc.
• Bio-Imaging will be responsible for site setup and standardization, centralized data translation and image standardization, image quantitation, design and implementation of its proprietary computer-assisted masked read system (CAMR), and preparation of a Bio/ImageBase package for regulatory submission.
• This contract highlights the acceptance and utility of Bio-Imaging's medical image processing technology and drug development expertise.
• Pharmacyclics, Inc. is a pharmaceutical company developing energy-potentiating drugs to improve radiation therapy and chemotherapy of cancer, and to enable or improve the photodynamic therapy of certain cancers and atherosclerotic cardiovascular disease.
• Bio-Imaging Technologies has provided total imaging solutions for clinical trials since 1990 and serves clients globally through its Corporate headquarters and regional offices.

Statistics:

• The contract between Bio-Imaging Technologies and Pharmacyclics, Inc. is valued at approximately $1.1 million.
• The partnership between the two companies has existed for four years.

Sources:

• PRNewswire, "Bio-Imaging Technologies, Inc. Signs $1.1 Million Contract with Pharmacyclics, Inc. to Support Phase III Clinical Trial," August 13, 1998.
• Press release from Bio-Imaging Technologies, Inc., "Bio-Imaging Technologies, Inc. Signs $1.1 Million Contract with Pharmacyclics, Inc. to Support Phase III Clinical Trial," August 13, 1998.